EU Jury

EU Jury

 
 

The Jury of the EU Health Award 2017 for NGOs promoting vaccination has been appointed and is currently evaluating the 27 applications received, according to the criteria established for the Award. The Jury is composed by 1 chair and 7 evaluators with expertise in the field of European public health. Some Jury members have a specific focus on vaccination.

The European Commission awards the prize on the basis of a proposal from the Jury. The Jury will establish a shortlist of candidate submissions for the EU Health Award 2017 on Vaccination of those projects that are being considered as good practices. The shortlisted candidates will be announced by European Health Commissioner Vytenis Andriukaits during the 20th European Health Forum Gastein on 6 October in Bad Hofgastein (Austria). This announcement will also be reported through Commission Twitter (@EU_Health) and the EU Health Policy Platform.

The three winners of the Award will be announced during the EU Health Policy Platform meeting on 27 November, in Brussels. Commissioner Vytenis Andriukaitis will then handover the EU Health Award 2017 on Vaccination.

Please be aware that announced dates may be subject to change.

 

woman

Chair - Dr. Isabel de la Mata

Dr. Isabel de la Mata is currently the Principal Adviser for Health and Crisis Management in the European Commission.
Previously, she worked as Counsellor for Health and Consumers at the Permanent Representation of Spain to the EU, as Deputy Director General for Health Planning at the Spanish Ministry of Health and as Advisor to the Vice-Minister of Health. In addition, she has been a member of the Standing Commission of the Regional Committee, the Pan-American Health Organisation, the Inter-American Development Bank and the Spanish Agency for International Cooperation. Dr. de la Mata graduated in Medicine and Surgery at the University of the Basque Country in 1983 and holds post-graduate degrees from the University of Leuven and Paris. She is a specialist in Preventive Medicine and Public Health.

woman

Dr. Andrea Ammon

Dr Andrea Ammon, MD, MPH, was formally appointed as the new Director of ECDC for a period of five years by the ECDC Management Board on 16 June 2017. Andrea joined ECDC as the Head of the Surveillance Unit in 2005. From April 2011 to April 2015, Andrea Ammon was Deputy to the Director and Head of Unit for Resource Management and Coordination.
Prior to joining the ECDC, Dr. Ammon served in several roles at the Robert Koch-Institute, in Berlin, Germany, notably as Head of Department for Infectious Disease Epidemiology. In this capacity, she maintained and further developed the German national surveillance system; directed the national Field Epidemiology Training Programme; coordinated epidemiological research programmes in infectious diseases, and provided scientific advice for government Ministries, Members of Parliament, and the public.

Prof. Geneviève Chene

Professor of medicine in biostatistics and public health since 1999, Geneviève Chêne is currently the Director of the Bordeaux school of public health (ISPED) at the University of Bordeaux. In 2017, she was nominated as coordinator of the EU-joint action on vaccination led by France, to strengthen cooperation across EU countries and improve vaccine coverage. As a researcher, Geneviève has established and led until 2015 an Inserm team on “HIV infections and associated morbidity” and a Clinical Trials Unit ("CMG-EC") as a platform of excellence for national and international trials. Since 2010, as co-principal investigator of Memento, a national cohort of 2,300 participants recruited in memory clinics, her research is transitioning from HIV and infectious diseases towards dementia a the Inserm U1219, while remaining actively involved in vaccine trials of emerging diseases (Ebola) and capacity-building in affected countries.

Ms Heather Deehan

Heather Deehan is the Chief, Vaccine Centre, UNICEF Supply Division, overseeing the supply and procurement of vaccines on behalf of over 100 countries. In 2016, UNICEF procured over 1.6 billion doses of vaccines, delivering vaccines on behalf of approximately 45% of the world’s children under 5. Before joining UNICEF, Heather was the Chief, Vaccine Preventable Diseases at the Public Health Agency of Canada, leading a team of epidemiologists in surveillance and outbreak response activities of vaccines preventable diseases in Canada, in addition to contributing to surveillance of Acute Flaccid Paralysis, measles and rubella, contributing to global eradication and elimination initiatives. Heather has also worked in pandemic preparedness and response, immunization surveillance activities including automated identification of vaccine products for inventory management at the national level.

woman

Dr. Odile Launay

Odile Launay is a medical doctor specialised in infectious diseases, HIV therapy and vaccinology. She is professor in infectious diseases since 2002 and is the head coordinator of the Cochin-Pasteur Clinical Research Centre “Centre d’Investigation Clinique Cochin Pasteur” (CIC 1417), a clinical investigation centre specialized in vaccine research, and of the French network I-REIVAC. The CIC is a public structure under the supervision of Inserm, Pasteur Institute, University Paris Descartes and the DGOS. At the CIC Cochin Pasteur, Odile Launay and her team elaborates and carries out clinical trials in the fields of preventive vaccination; therapeutic vaccination and specific immunotherapy in specific clinical infections, tumoral diseases and immunological-related diseases. In particular, Dr. Launay overseas the implementation of clinical trials for the assessment of various vaccine formulae and the vaccination of special populations.

woman

Dr. Line Matthiessen

Line Matthiessen is acting Director of the Directorate for Health, in the Directorate-General for Research and Innovation. Her responsibilities include providing overall strategic orientation and management of the Health Research Directorate. Represent the EC in European and international meetings including in negotiations with governments, non-governmental organisations, patient organisations, as well as work on novel financial instruments with colleagues in DG RTD and the European Investment Bank. She is also the Head of Unit responsible for Fighting Infectious Diseases and Advancing Public Health. Dr Matthiessen was Head of Unit for horizontal aspects and coordination in the Directorate for Biotechnologies, Agriculture and Food Research from July 2007 to December 2010. She is a member of the management board of the European Centre for Disease Control and of several advisory boards. Line Matthiessen was trained as an MD at the University of Odense, Denmark and received her PhD in Neurosciences from the University of Paris VI, France in 1993.

Prof. Guido Rasi

Professor Guido Rasi began his second term as Executive Director of EMA on 16 November 2015. From November 2014 to mid-November 2015, Professor Guido Rasi served as EMA’s Principal Adviser in Charge of Strategy.
From November 2011 to November 2014 he was the Executive Director of the European Medicines Agency. He was Director-General of the Italian Medicines Agency from 2008 to 2011 and member of the Management Board from 2004 and 2008.
He was made professor of microbiology at the University of Rome 'Tor Vergata' in 2008. From 1990 to 2005 Professor Rasi worked at the Institute for Experimental Medicine of the National Research Council, Italy. Professor Rasi holds a degree in medicine and surgery, with specialisations in internal medicine, allergology and clinical immunology, from the University of Rome.

Dr. Aura Timen

Aura Timen received a medical degree from the Free University (VU) of Amsterdam and has registered as specialist in community medicine (with a sub-specialization in communicable disease control) with the Royal Society of Medicine of the Netherlands (KNMG). She is Head of the National Coordination Centre for Communicable Disease Control (LCI), which is part of the Centre for Infectious Disease Control of the National Institute for Public Health and the Environment (RIVM). Aura Timen holds a PhD in outbreak management from the Radboud University Nijmegen, The Netherlands. She participates in various (international) projects aiming to strengthen the capacity to prepare and respond to epidemics and threats. In November 2012 she became president of the section Infectious Disease Control of the European Public Health Association (EUPHA).